Generation Bio Dirección
Dirección controles de criterios 3/4
El CEO de Generation Bio es Geoff McDonough , nombrado en Oct 2017, tiene una permanencia de 7.08 años. compensación anual total es $2.32M, compuesta por 27.2% salario y 72.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 2.75% de las acciones de la empresa, por valor de $2.57M. La antigüedad media del equipo directivo y de la junta directiva es de 3.5 años y 6.9 años, respectivamente.
Información clave
Geoff McDonough
Chief Executive Officer (CEO)
US$2.3m
Compensación total
| Porcentaje del salario del CEO | 27.2% |
| Permanencia del CEO | 7.1yrs |
| Participación del CEO | 2.8% |
| Permanencia media de la dirección | 3.5yrs |
| Promedio de permanencia en la Junta Directiva | 6.9yrs |
Actualizaciones recientes de la dirección
Recent updates
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth
May 01
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth
Dec 07Companies Like Generation Bio (NASDAQ:GBIO) Can Afford To Invest In Growth
Jul 11We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely
Mar 11Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans
Nov 19We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely
Aug 05Generation Bio GAAP EPS of -$0.66 misses by $0.04
Aug 04Companies Like Generation Bio (NASDAQ:GBIO) Are In A Position To Invest In Growth
Apr 20Generation Bio: High-Risk, Medium-To-Low-Reward
Dec 30We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth
Nov 11We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth
Jul 28Here's Why We're Not Too Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation
Mar 08Trade Alert: The Independent Director Of Generation Bio Co. (NASDAQ:GBIO), Charles Rowland, Has Just Spent US$500k Buying 25% More Shares
Jan 14
Generation Bio's insiders on buying spree, stock +4%
Jan 13Generation Bio prices equity offering at $24.50
Jan 07Generation Bio files to offer 7.5M shares
Jan 04Should You Take Comfort From Insider Transactions At Generation Bio Co. (NASDAQ:GBIO)?
Dec 27Generation Bio EPS misses by $0.01
Nov 10Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$145m |
| Jun 30 2024 | n/a | n/a | -US$158m |
| Mar 31 2024 | n/a | n/a | -US$169m |
| Dec 31 2023 | US$2m | US$630k | -US$127m |
| Sep 30 2023 | n/a | n/a | -US$124m |
| Jun 30 2023 | n/a | n/a | -US$127m |
| Mar 31 2023 | n/a | n/a | -US$134m |
| Dec 31 2022 | US$4m | US$606k | -US$137m |
| Sep 30 2022 | n/a | n/a | -US$135m |
| Jun 30 2022 | n/a | n/a | -US$136m |
| Mar 31 2022 | n/a | n/a | -US$129m |
| Dec 31 2021 | US$6m | US$583k | -US$119m |
| Sep 30 2021 | n/a | n/a | -US$112m |
| Jun 30 2021 | n/a | n/a | -US$101m |
| Mar 31 2021 | n/a | n/a | -US$88m |
| Dec 31 2020 | US$2m | US$516k | -US$81m |
| Sep 30 2020 | n/a | n/a | -US$72m |
| Jun 30 2020 | n/a | n/a | -US$68m |
| Mar 31 2020 | n/a | n/a | -US$65m |
| Dec 31 2019 | US$593k | US$424k | -US$61m |
Compensación vs. Mercado: La compensación total de Geoff($USD2.32M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD647.72K).
Compensación vs. Ingresos: La compensación de Geoff ha sido consistente con los resultados de la empresa en el último año.
CEO
Geoff McDonough (54 yo)
7.1yrs
Permanencia
US$2,315,263
Compensación
Dr. Cameron Geoffrey McDonough, also known as Geoff, M.D. serves as Independent Director of Third Harmonic Bio, Inc. since March 2024. He had been an Independent Director of Surface Oncology, Inc. since Fe...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 7.1yrs | US$2.32m | 2.75% $ 2.6m | |
| Chief Financial Officer | 4.3yrs | US$1.14m | 0.086% $ 80.3k | |
| Chief Scientific Officer | 5.5yrs | US$1.15m | 0.37% $ 346.2k | |
| Chief Legal Officer & Secretary | 1.6yrs | US$1.21m | 0.021% $ 19.9k | |
| Co-Founder | 8.1yrs | sin datos | sin datos | |
| Co-Founder | no data | sin datos | sin datos | |
| Chief Operating Officer | 2.8yrs | sin datos | 0.024% $ 22.5k | |
| Chief Human Resources Officer | 1.7yrs | sin datos | sin datos | |
| Chief Strategy Officer | 2.2yrs | sin datos | 0.18% $ 170.9k |
3.5yrs
Permanencia media
51yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de GBIO se considera experimentado (3.5 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 7.1yrs | US$2.32m | 2.75% $ 2.6m | |
| Independent Chairman | 7.1yrs | US$181.21k | 0% $ 0 | |
| Independent Director | 6.9yrs | US$143.71k | 0.20% $ 184.0k | |
| Independent Director | 6.3yrs | US$151.21k | 0.80% $ 748.7k | |
| Independent Director | 6.9yrs | US$143.71k | 0.24% $ 225.9k | |
| Chairman of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 6.9yrs | US$143.71k | 0.32% $ 299.0k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 3.7yrs | US$144.21k | 0.014% $ 13.3k | |
| Independent Director | 6.9yrs | US$143.71k | 0.071% $ 66.5k | |
| Member of Scientific Advisory Board | 6.1yrs | sin datos | sin datos |
6.9yrs
Permanencia media
61yo
Promedio de edad
Junta con experiencia: La junta directiva de GBIO se considera experimentada (6.9 años de antigüedad promedio).